Physician profile
William Hertz
NPI 1457138166
$909.16
in general payments reported to CMS, 2019-2025
18 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $36.93 · 2024: $412 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $157.70 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.51 | 2025 | |
| Amgen INC. | $107.46 | 2024-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $98.56 | 2024-2025 | Wainua, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $60.14 | 2024-2025 | Camzyos |
| Medtronic, INC. | $57.45 | 2024 | Corevalve Evolut R |
| Kiniksa Pharmaceuticals International, Plc | $56.18 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $52.64 | 2025 | Opsumit, Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.13 | 2024-2025 | Lifevest |
| Ethicon US, LLC | $34.42 | 2025 | Stratafix |
| Lexicon Pharmaceuticals, INC. | $19.44 | 2024 | |
| Bridgebio Pharma, INC. | $18.21 | 2025 | Attruby |
| United Therapeutics Corporation | $17.73 | 2025 | Tyvaso |
| Janssen Pharmaceuticals, INC | $16.06 | 2024 | Xarelto |
| Ultragenyx Pharmaceutical INC. | $15.34 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $14.85 | 2024 | Stelara |
| Convatec INC. | $14.21 | 2025 | |
| Novartis Pharmaceuticals Corporation | $13.13 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hertz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.